Kjeldsen-Kragh J - Search Results

1

The pathophysiology of FNAIT cannot be deduced from highly selected retrospective data.

Kjeldsen-Kragh J, Husebekk A, Killie MK, Skogen B. Kjeldsen-Kragh J, et al. Blood. 2011 Sep 1;118(9):2638-9. doi: 10.1182/blood-2011-06-360404. Blood. 2011. PMID: 21885616 Free article. No abstract available.

2

A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia.

Kjeldsen-Kragh J, Killie MK, Tomter G, Golebiowska E, Randen I, Hauge R, Aune B, Øian P, Dahl LB, Pirhonen J, Lindeman R, Husby H, Haugen G, Grønn M, Skogen B, Husebekk A. Kjeldsen-Kragh J, et al. Blood. 2007 Aug 1;110(3):833-9. doi: 10.1182/blood-2006-08-040121. Epub 2007 Apr 11. Blood. 2007. PMID: 17429009 Free article. Clinical Trial.

3

Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health care programme?

Kjeldsen-Kragh J, Husebekk A, Killie MK, Skogen B. Kjeldsen-Kragh J, et al. Transfus Apher Sci. 2008 Jun;38(3):183-8. doi: 10.1016/j.transci.2008.04.010. Epub 2008 May 21. Transfus Apher Sci. 2008. PMID: 18499524 Review.

4

Is it time to implement HPA-1 screening in pregnancy?

Husebekk A, Killie MK, Kjeldsen-Kragh J, Skogen B. Husebekk A, et al. Curr Opin Hematol. 2009 Nov;16(6):497-502. doi: 10.1097/MOH.0b013e3283317be9. Curr Opin Hematol. 2009. PMID: 19730261 Review.

5

Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention.

Skogen B, Killie MK, Kjeldsen-Kragh J, Ahlen MT, Tiller H, Stuge TB, Husebekk A. Skogen B, et al. Expert Rev Hematol. 2010 Oct;3(5):559-66. doi: 10.1586/ehm.10.49. Expert Rev Hematol. 2010. PMID: 21083473 Review.

6

Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys.

Tiller H, Killie MK, Husebekk A, Skogen B, Ni H, Kjeldsen-Kragh J, Øian P. Tiller H, et al. Acta Obstet Gynecol Scand. 2012 Jan;91(1):79-86. doi: 10.1111/j.1600-0412.2011.01269.x. Epub 2011 Oct 13. Acta Obstet Gynecol Scand. 2012. PMID: 21895612 Free article.

7

The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes.

Ahlen MT, Husebekk A, Killie MK, Kjeldsen-Kragh J, Olsson ML, Skogen B. Ahlen MT, et al. Clin Dev Immunol. 2012;2012:156867. doi: 10.1155/2012/156867. Epub 2011 Nov 2. Clin Dev Immunol. 2012. PMID: 22110529 Free PMC article.

8

The prevalence of HPA-1a alloimmunization and the potential risk of FNAIT depend on both the DRB3*01:01 allele and associated DR-DQ haplotypes.

Ahlen MT, Heide G, Husebekk A, Skogen B, Kjeldsen-Kragh J, Stuge TB. Ahlen MT, et al. Scand J Immunol. 2020 Jul;92(1):e12890. doi: 10.1111/sji.12890. Epub 2020 May 17. Scand J Immunol. 2020. PMID: 32299122 Free article.

9

Neonatal alloimmune thrombocytopenia is not what it was: a lesson learned from a large prospective screening and intervention program.

Skogen B, Husebekk A, Killie MK, Kjeldsen-Kragh J. Skogen B, et al. Scand J Immunol. 2009 Dec;70(6):531-4. doi: 10.1111/j.1365-3083.2009.02339.x. Scand J Immunol. 2009. PMID: 19906194 Free article. Review.

10

Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.

Tiller H, Killie MK, Chen P, Eksteen M, Husebekk A, Skogen B, Kjeldsen-Kragh J, Ni H. Tiller H, et al. Transfusion. 2012 Jul;52(7):1446-57. doi: 10.1111/j.1537-2995.2011.03480.x. Epub 2012 Jan 17. Transfusion. 2012. PMID: 22251227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page